March 23, 2016

Louder Than TB: TB Alliance joins health leaders to call attention to burden of childhood TB

Working together, we can give voice to the voiceless
March 11, 2016

Phase 1 Clinical Trial of TB Drug Candidate TBA-354 Discontinued

More investment is needed to expand the portfolio of new TB drug candidates
January 4, 2016

Phase 1 TBA-354 Placed on Clinical Hold

TB Alliance announced today that it has voluntarily halted further dosing of TBA-354 in the ongoing Multiple Ascending Dose (MAD) Phase 1 study.
May 13, 2015

TB Alliance Launches “Nix-TB” Clinical Trial to Test New XDR-TB Treatment

First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB
March 23, 2015

Australia Grants Support for TB Alliance to Advance New TB Drugs

New funding supports new tools critical for tackling TB in the Asia-Pacific region and around the world

Pages